KOCI, ARIOLA

KOCI, ARIOLA  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Mostra records
Risultati 1 - 20 di 22 (tempo di esecuzione: 0.051 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. Poluzzi E;Raschi E;Koci A;Moretti U;Spina E;Behr ER;Sturkenboom M;De Ponti F 2013-01-01 DRUG SAFETY - 1.01 Articolo in rivista -
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy Lodato, Francesca; Poluzzi, Elisabetta; Raschi, Emanuel; Piccinni, Carlo; Koci, Ariola; Olivelli,... Valentina; Napoli, Chiara; Corvalli, Giulia; Nalon, Elena; De Ponti, Fabrizio; Zoli, Marco 2016-01-01 EUROPEAN JOURNAL OF INTERNAL MEDICINE - 1.01 Articolo in rivista -
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database Raschi, Emanuel; Poluzzi, Elisabetta; Koci, Ariola; Caraceni, Paolo; De Ponti, Fabrizio 2014-01-01 WORLD JOURNAL OF HEPATOLOGY - 1.01 Articolo in rivista -
Association between Paraesthesia and Local Anesthetics: Data Mining of the Public Version of the FDA Adverse Event Reporting System, Piccinni C; Gissi DB; Koci A; Servidio D; Cervellati F; Poluzzi E. 2013-01-01 DRUG SAFETY Adis 4.03 Poster -
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project Raschi, Emanuel; Poluzzi, Elisabetta; Salvo, Francesco; Koci, Ariola; Suling, Marc; Antoniazzi, S...tefania; Perina, Luisella; Hazell, Lorna; Moretti, Ugo; Sturkenboom, Miriam; Garbe, Edeltraut; Pariente, Antoine; de Ponti, Fabrizio 2016-01-01 DRUG SAFETY - 1.01 Articolo in rivista -
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System Raschi, Emanuel; Poluzzi, Elisabetta; Koci, Ariola; Antonazzo, IPPAZIO COSIMO; MARCHESINI REGGIAN...I, Giulio; DE PONTI, Fabrizio 2016-01-01 NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES - 1.01 Articolo in rivista -
Fattori determinanti nell'utilizzo dei farmaci antipsicotici Piazza A; Piccinni C; Poluzzi E; Koci A; Tarricone I; Berardi D; De Ponti F; Fioritti A 2011-01-01 - - 4.02 Riassunto (Abstract) -
Liver injury with novel oral anticoagulants: Assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system Raschi, Emanuel; Poluzzi, Elisabetta; Koci, Ariola; Salvo, Francesco; Pariente, Antoine; Biselli,... Maurizio; Moretti, Ugo; Moore, Nicholas; De Ponti, Fabrizio 2015-01-01 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit Girardi, A.; Galletti, S.; Raschi, E.; Koci, A.; Poluzzi, E.; Faldella, G.; De Ponti, F. 2017-01-01 THE ITALIAN JOURNAL OF PEDIATRICS - 1.01 Articolo in rivista It_J_Ped_2017.pdf
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) Piccinni C; Poluzzi E; Tarricone I; Piazza A; Koci A; Berardi D; De Ponti F 2011-01-01 - - 4.02 Riassunto (Abstract) -
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe Poluzzi, Elisabetta; Raschi, Emanuel; Godman, Brian; Koci, Ariola; Moretti, Ugo; Kalaba, Marija; ...Wettermark, Bjorn; Sturkenboom, Miriam; De Ponti, Fabrizio 2015-01-01 PLOS ONE - 1.01 Articolo in rivista pone.0119551.pdf
Profili di utilizzo dei farmaci antipsicotici nei centri salute mentale della AUSL di Bologna: determinanti clinici e sociali Piccinni C; Piazza A; Poluzzi E; Tarricone I; Koci A; Berardi D; Fioritti A; De Ponti F 2012-01-01 ISTISAN CONGRESSI - 4.02 Riassunto (Abstract) -
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus Raschi E; Poluzzi E; Koci A; Boriani G; De Ponti F. 2011-01-01 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY - 1.04 Replica / breve intervento (e simili) -
QT shortening among suspected adverse drug reactions reported to the FDA: a case-by-case analysis E. Raschi; E. Poluzzi; A. Koci; G. Boriani; F. De Ponti 2011-01-01 BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY - 4.02 Riassunto (Abstract) -
Reporting frequency of QT-interval abnormalities in the FDA Adverse Event Reporting System (FDA_AERS). E. Raschi; E. Poluzzi; A. Koci; F. De Ponti 2011-01-01 BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY - 4.02 Riassunto (Abstract) -
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature G. Roberto; C. Biagi; N. Montanaro; A. Koci; U. Moretti; D. Motola 2012-01-01 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy Poluzzi, Elisabetta; Veronese, Giacomo; Piccinni, Carlo; Raschi, Emanuel; Koci, Ariola; Pagano, P...aola; Godman, Brian; MARCHESINI REGGIANI, Giulio; Boriani, Giuseppe; DE PONTI, Fabrizio 2016-01-01 BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY - 1.01 Articolo in rivista -
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. Raschi E;Poluzzi E;Godman B;Koci A;Moretti U;Kalaba M;Bennie M;Barbui C;Wettermark B;Sturkenboom ...M;De Ponti F 2013-01-01 PLOS ONE - 1.01 Articolo in rivista journal.pone.0081208.PDFpone.0081208.s001.docxpone.0081208.s002.docx
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database Roberto G; Piccinni C; Biagi C; Koci A; Motola D; Vaccheri A; Montanaro N; Poluzzi E. 2012-01-01 PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Wiley Blackewell 4.02 Riassunto (Abstract) -
Use and Perception of Phytoestrogens in Postmenopausal Women: Result of a Questionnaire-Based Survey C. Piccinni; E. Poluzzi; E. Raschi; B. Vitamia; A. Koci; F. De Ponti 2013-01-01 DRUG SAFETY Adis 4.03 Poster -